Cooperative Research Australia (CRA) revealed four award recipients at its 2021 Excellence in Innovation Awards, held as part of the Collaborate Innovate Conference. [ + ]

Over the next four years, the fund will support international collaboration to enhance Australia's profile in science and technology research and application. [ + ]

Scientists investigated the anti-obesity effects of fermented okara on mice put on a three-week high-fat diet compared to mice put on three other types of diet. [ + ]

The TGA has provisionally approved Pfizer's COVID-19 vaccine for use as a booster in individuals aged 12 to 15 years old — but ATAGI has failed to follow suit. [ + ]

The spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs). [ + ]

Immediate and deep emissions reductions are required across all sectors in order to limit global warming to 1.5°C, the latest IPCC report says. [ + ]

For people with atrial fibrillation, one of the most common cardiac disorders, dementia risk is elevated. [ + ]

In warmer water, soundwaves propagate faster and last longer before dying away. [ + ]

A single-shot immunisation containing the M2e peptide is able to trigger long-lasting immune responses that could protect against multiple strains of influenza. [ + ]

The new method combines macro photography of the captured insects with DNA metabarcoding, a cutting-edge insect identification tool. [ + ]

The awards recognise the top-ranked applicants to each of NHMRC's major funding schemes during the past year. [ + ]

The Australian Senate has voted to allow the passage of Maeve's Law — a Bill that legalises mitochondrial donation. [ + ]

Muscular dystrophy is a debilitating disease that causes the weakness and breakdown of skeletal muscles that progressively worsens over time. [ + ]

A simple blood test for the adrenal disease known as primary aldosteronism could save hypertension patients from unnecessary illness, medication and expense. [ + ]

Researchers are looking for 114 healthy people aged 18–70 living in Victoria to roll up their sleeves for a Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines. [ + ]